Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Diabetic basement membrane thickening does not occur in myocardial capillaries of transgenic mice when metallothionein is overexpressed in cardiac myocytes.

Velic A, Laturnus D, Chhoun J, Zheng S, Epstein P, Carlson E.

Anat Rec (Hoboken). 2013 Mar;296(3):480-7. doi: 10.1002/ar.22646. Epub 2013 Feb 4.

2.

[Cardiac metallothionein overexpression improves cardiac contractile function and attenuates oxidative stress in lipopolysaccharide-treated mice].

Zhao P, Zhang J, Chu X, Yuan HT, Cui LQ, Zhu XL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Aug;39(8):711-6. Chinese.

PMID:
22169416
3.

Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice.

Carlson EC, Audette JL, Veitenheimer NJ, Risan JA, Laturnus DI, Epstein PN.

Anat Rec A Discov Mol Cell Evol Biol. 2003 Apr;271(2):332-41.

4.

Overexpression of metallothionein reduces diabetic cardiomyopathy.

Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN.

Diabetes. 2002 Jan;51(1):174-81.

5.

Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.

Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, Kang YJ.

J Am Coll Cardiol. 2006 Oct 17;48(8):1688-97. Epub 2006 Sep 27.

6.

Metallothionein-I/II null cardiomyocytes are sensitive to Fusarium mycotoxin butenolide-induced cytotoxicity and oxidative DNA damage.

Yang HY, Wang YM, Peng SQ.

Toxicon. 2010 Jun 15;55(7):1291-6. doi: 10.1016/j.toxicon.2010.01.022. Epub 2010 Feb 6.

PMID:
20144643
7.
8.

Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.

Zhou G, Li X, Hein DW, Xiang X, Marshall JP, Prabhu SD, Cai L.

J Am Coll Cardiol. 2008 Aug 19;52(8):655-66. doi: 10.1016/j.jacc.2008.05.019.

9.

Renoprotection From Diabetic Complications in OVE Transgenic Mice by Endothelial Cell Specific Overexpression of Metallothionein: A TEM Stereological Analysis.

Carlson EC, Chhoun JM, Grove BD, Laturnus DI, Zheng S, Epstein PN, Tan Y.

Anat Rec (Hoboken). 2017 Mar;300(3):560-576. doi: 10.1002/ar.23511. Epub 2017 Jan 11.

10.

Cardiac overexpression of metallothionein rescues cold exposure-induced myocardial contractile dysfunction through attenuation of cardiac fibrosis despite cardiomyocyte mechanical anomalies.

Zhang Y, Hu N, Hua Y, Richmond KL, Dong F, Ren J.

Free Radic Biol Med. 2012 Jul 15;53(2):194-207. doi: 10.1016/j.freeradbiomed.2012.04.005. Epub 2012 May 5.

12.

Zinc supplementation prevents cardiomyocyte apoptosis and congenital heart defects in embryos of diabetic mice.

Kumar SD, Vijaya M, Samy RP, Dheen ST, Ren M, Watt F, Kang YJ, Bay BH, Tay SS.

Free Radic Biol Med. 2012 Oct 15;53(8):1595-606. doi: 10.1016/j.freeradbiomed.2012.07.008. Epub 2012 Jul 20.

PMID:
22819979
13.

Basal metallothionein-I/II protects against NMDA-mediated oxidative injury in cortical neuron/astrocyte cultures.

Yu X, Guo J, Fang H, Peng S.

Toxicology. 2011 Mar 28;282(1-2):16-22. doi: 10.1016/j.tox.2010.12.008. Epub 2011 Jan 6.

PMID:
21215786
14.

Podocyte-specific overexpression of metallothionein mitigates diabetic complications in the glomerular filtration barrier and glomerular histoarchitecture: a transmission electron microscopy stereometric analysis.

Carlson EC, Chhoun JM, Laturnus DI, Bikash KC, Berg B, Zheng S, Epstein PN.

Diabetes Metab Res Rev. 2013 Feb;29(2):113-24. doi: 10.1002/dmrr.2342.

PMID:
22926941
15.

Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes.

Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, Epstein PN.

Diabetes. 2004 May;53(5):1336-43.

16.

Prior increase in metallothionein levels is required to prevent doxorubicin cardiotoxicity.

Sun X, Kang YJ.

Exp Biol Med (Maywood). 2002 Sep;227(8):652-7.

PMID:
12192109
17.

Cardiac-specific overexpression of metallothionein rescues nicotine-induced cardiac contractile dysfunction and interstitial fibrosis.

Hu N, Guo R, Han X, Zhu B, Ren J.

Toxicol Lett. 2011 Apr 10;202(1):8-14. doi: 10.1016/j.toxlet.2011.01.007. Epub 2011 Jan 14.

18.

Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart.

Xue W, Liu Y, Zhao J, Cai L, Li X, Feng W.

Am J Physiol Heart Circ Physiol. 2012 Jun 15;302(12):H2528-35. doi: 10.1152/ajpheart.00850.2011. Epub 2012 Apr 20.

20.

Supplemental Content

Support Center